Literature DB >> 20045594

RNA polymerase - an important molecular target of triptolide in cancer cells.

Jingxuan Pan1.   

Abstract

Triptolide, a diterpenoid triepoxide, is the key biological component of Tripterygium wilfordii Hook. f. which was used in traditional Chinese medicine for centuries to treat inflammation and autoimmune diseases. Triptolide has shown potent activity in not only anti-inflammation and immune modulation, but also antiproliferative and proapoptotic activity in many different types of cancer cells. However, for a long time, the precise molecular target(s) of triptolide have remained elusive. Recently, several groups discovered that triptolide inhibited the activity of RNA polymerase. This review will focus on these breakthrough findings about the molecular target of triptolide and its implications for targeted-cancer therapeutics. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045594     DOI: 10.1016/j.canlet.2009.11.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  27 in total

1.  Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'.

Authors:  Li Lu; Jyoti Kanwar; Sara Schmitt; Qiuzhi Cindy Cui; Chuanyin Zhang; Cong Zhao; Q Ping Dou
Journal:  Anticancer Res       Date:  2011-01       Impact factor: 2.480

2.  XPB, a subunit of TFIIH, is a target of the natural product triptolide.

Authors:  Denis V Titov; Benjamin Gilman; Qing-Li He; Shridhar Bhat; Woon-Kai Low; Yongjun Dang; Michael Smeaton; Arnold L Demain; Paul S Miller; Jennifer F Kugel; James A Goodrich; Jun O Liu
Journal:  Nat Chem Biol       Date:  2011-01-30       Impact factor: 15.040

3.  Triptolide downregulates human GD3 synthase (hST8Sia I) gene expression in SK-MEL-2 human melanoma cells.

Authors:  Haw-Young Kwon; Seok-Jo Kim; Cheorl-Ho Kim; Sung-Wook Son; Kyoung-Sook Kim; Jai-Heon Lee; Su-Il Do; Young-Choon Lee
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

4.  Triptolide directly inhibits dCTP pyrophosphatase.

Authors:  Timothy W Corson; Hüseyin Cavga; Nicholas Aberle; Craig M Crews
Journal:  Chembiochem       Date:  2011-06-10       Impact factor: 3.164

Review 5.  Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.

Authors:  Rui Han; Martin Rostami-Yazdi; Sascha Gerdes; Ulrich Mrowietz
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

6.  Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation.

Authors:  Hu Xiaowen; Sun Yi
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

7.  MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML.

Authors:  B Z Carter; D H Mak; Y Shi; J M Fidler; R Chen; X Ling; W Plunkett; M Andreeff
Journal:  Leukemia       Date:  2011-09-09       Impact factor: 11.528

8.  Triptolide induces Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of the mitochondrial pathway and inhibition of Nrf2-mediated antioxidant response.

Authors:  Yu Wang; Su-Han Guo; Xue-Jun Shang; Li-Sha Yu; Jian-Wei Zhu; Ang Zhao; Yan-Fen Zhou; Guo-Hua An; Qi Zhang; Bo Ma
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

9.  Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl.

Authors:  Zhongzheng Lu; Yanli Jin; Chun Chen; Juan Li; Qi Cao; Jingxuan Pan
Journal:  Mol Cancer       Date:  2010-05-19       Impact factor: 27.401

10.  Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.

Authors:  Fethia Ben Yebdri; Julien Van Grevenynghe; Vera A Tang; Marie-Line Goulet; Jian Hui Wu; David F Stojdl; John Hiscott; Rongtuan Lin
Journal:  Mol Ther       Date:  2013-08-28       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.